HS Icon Vaccines, human use in  Flag Japan

2019
Exports | Imports
: $55M | $287M, World Rnk 24 / 123
Flag Rnk 1061 / 4513 | World Rnk 18 / 215
Flag Rnk 345 / 4546

2018 - 2019
FASTEST GROWING MARKET | FASTEST GROWING ORIGIN
: $16M | $9.69M, Thailand |  Italy

2019
ECONOMIC COMPLEXITY of Japan
: 2.23, Rnk 1 / 147

2019
PRODUCT COMPLEXITY  IN Vaccines, human use
: 0.49, Rnk 1020 / 2764

Exports: In 2019, Japan exported $55M in Vaccines, human use, making it the 24th largest exporter of Vaccines, human use in the world. At the same year, Vaccines, human use was the 1061st most exported product in Japan. The main destination of Vaccines, human use exports from Japan are: Thailand ($16M), Chinese Taipei ($12.8M), South Korea ($12M), United States ($5.96M), and Malaysia ($3M).

The fastest growing export markets for Vaccines, human use of Japan between 2018 and 2019 were Thailand ($16M), Chinese Taipei ($11.8M), and United States ($5.77M).

Imports: In 2019, Japan imported $287M in Vaccines, human use, becoming the 18th largest importer of Vaccines, human use in the world. At the same year, Vaccines, human use was the 345th most imported product in Japan. Japan imports Vaccines, human use primarily from: Ireland ($94.4M), France ($66.6M), Belgium ($63.3M), United States ($41.4M), and Italy ($15M).

The fastest growing import markets in Vaccines, human use for Japan between 2018 and 2019 were Italy ($9.69M), Belgium ($3M), and Hong Kong ($635k).

Latest Trends (May 2021)

#permalink to section

Overview: In May 2021 Japan's Vaccines, human use exports accounted up to ¥513M and imports accounted up to ¥126B, resulting in a negative trade balance of ¥126B. Between May 2020 and May 2021 the exports of Japan's   Vaccines, human use have increased by ¥90.3M (21.3%) from ¥423M to ¥513M, while imports increased by ¥124B (5.7k%) from ¥2.18B to ¥126B.

Destinations: In May 2021, Vaccines, human use were exported mostly to Taiwan (¥445M), Bangladesh (¥28.6M), Iraq (¥20.2M), Burundi (¥14.4M), and Lesotho (¥3.29M), and were imported mostly from Belgium (¥85.8B), United States (¥23.6B), Spain (¥14.1B), Ireland (¥2B), and France (¥731M).

Growth: In May 2021, the increase in Vaccines, human use's year-by-year exports was explained primarily by an increase in exports to . In May 2021, the increase in Vaccines, human use's year-by-year imports was explained primarily by an increase in imports from Belgium (¥85.8B or 397k%), United States (¥22.6B or 2.26k%), and Ireland (¥1.99B or 36.9k%).

Subnational Monthly Trade

#permalink to section
Time Scale
Flow
Value

EXPORT GROWTH (May 2020 - May 2021): ¥90.3M, (21.3%)

IMPORT GROWTH (May 2020 - May 2021): ¥124B, (5.7k%)

MAIN EXPORTER (May 2021): Chiba, ¥289M

MAIN DESTINATION (May 2021): Taiwan, ¥445M

This section shows Vaccines, human use's exports and imports data at subnational level for Japan. Click any date in the line plot, any subnational region in the geomap, or any destination or origin country to explore the exports or imports behavior of Vaccines, human use over time.

For full datasets download visit Bulk Download page.

Go to Bulk Download

Historical Data

#permalink to section
Value

EXPORTS (2019): $55M

IMPORTS (2019): $287M

NET TRADE (2019): -$232M

In 2019, Japan exported $55M in Vaccines, human use. The main destinations of Japan exports on Vaccines, human use were Thailand ($16M), Chinese Taipei ($12.8M), South Korea ($12M), United States ($5.96M), and Malaysia ($3M).

In 2019, Japan imported $287M in Vaccines, human use, mainly from Ireland ($94.4M), France ($66.6M), Belgium ($63.3M), United States ($41.4M), and Italy ($15M).

Explore Visualizations

IN 2019, Japan HAD A POSITIVE NET TRADE IN Vaccines, human use WITH:

IN 2019, Japan HAD A NEGATIVE NET TRADE IN Vaccines, human use WITH:

Flow

THE FASTEST GROWING Vaccines, human use EXPORT MARKETS FOR Japan WERE (2018 - 2019):

THE FASTEST DECLINING MARKETS FOR THE EXPORT OF Vaccines, human use BY Japan WERE (2018 - 2019):

Explore Visualizations

Market Concentration

#permalink to section
Flow
Type

In 2018, Japan's main exporting competitors in Vaccines, human use were:

In 2018, Japan's main importing competitors in Vaccines, human use were:

Explore Visualizations

Tariffs by Country

#permalink to section

In 2018, the tariffs for Vaccines, human use in the imports of Japan were of 0% around the world.